XML 42 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity Incentive Plan (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
The table below presents share-based compensation expense and the estimated related tax benefit for stock options and restricted stock for the dates indicated below:
Three Months Ended March 31,
20242023
Share-based compensation expense$413 $434 
Tax benefit97 102 
Equity Incentive Plan Stock Option Activity
The table below presents stock option activity and related information for the three months ended March 31, 2024 and 2023:
OptionsWeighted-Average Exercise PriceRemaining Contractual Life
(Years)
Aggregate
Intrinsic
Value
Options outstanding at December 31, 2022849,623 $22.06 3.9$2,958 
Exercised(277,549)14.65 
Forfeited(1,500)14.37 
Options outstanding at March 31, 2023570,574 $25.68 5.3$327 
Exercisable at March 31, 2023493,764 $25.39 4.9$287 
Non-vested at March 31, 202376,810 $27.55 8.2$40 
Options outstanding at December 31, 2023534,350 $25.85 4.6$776 
Exercised(10,000)15.80 
Options outstanding at March 31, 2024524,350 $26.04 4.5$848 
Exercisable at March 31, 2024475,380 $25.86 4.2$774 
Non-vested at March 31, 202448,970 $27.77 7.4$74 
Schedule of Nonvested Restricted Stock Units Activity
The table below presents restricted stock award activity and related information:
Restricted
Stock Awards(1)
Performance-Based Restricted
Stock Units(2)
Weighted-
Average Grant
Date Fair Value
Aggregate
Intrinsic
Value
Non-vested at December 31, 2022100,992 22,843 $27.28 $2,033 
Granted53,339 17,519 27.45 
Vested(41,588)— 27.47 
Non-vested at March 31, 2023112,743 40,362 $27.14 $3,916 
Non-vested at December 31, 2023106,143 25,001 $27.70 $3,530 
Granted56,480 15,899 26.58 
Vested(36,637)— 27.26 
Non-vested at March 31, 2024125,986 40,900 $27.31 $4,563 
(1)Restricted stock awards are scheduled to vest over 1.0 year for director awards and 5.0 years for employee awards.
(2)Performance-based restricted stock units are scheduled to vest over 3.0 years assuming the applicable financial goals are met.